{"id":"https://openalex.org/W2517864759","doi":"https://doi.org/10.1186/s12885-016-2734-y","title":"Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis","display_name":"Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis","alternate_titles":[],"publication_year":2016,"publication_date":"2016-08-24","ids":{"openalex":"https://openalex.org/W2517864759","doi":"https://doi.org/10.1186/s12885-016-2734-y","mag":"2517864759","pmid":"https://pubmed.ncbi.nlm.nih.gov/27558497","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4997727"},"language":"en","primary_location":{"id":"doi:10.1186/s12885-016-2734-y","doi":"https://doi.org/10.1186/s12885-016-2734-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-016-2734-y","pdf_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-016-2734-y","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2517864759"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-016-2734-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Tobias Engel Ayer Botrel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115148","display_name":"Kantar Health (Brazil)","ror":"https://ror.org/01j4fzm59","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210115148"]}],"countries":["BR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tobias Engel Ayer Botrel","raw_affiliation_strings":["CIOP - Centro Integrado de Oncologia e Pesquisa, Rua Santo Ant\u00f4nio 200, sala 301, Po\u00e7os de Caldas, Minas Gerais, Brazil, 37701-036. tobias.engel@evidencias.com.br","Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123. tobias.engel@evidencias.com.br","Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIOP - Centro Integrado de Oncologia e Pesquisa, Rua Santo Ant\u00f4nio 200, sala 301, Po\u00e7os de Caldas, Minas Gerais, Brazil, 37701-036. tobias.engel@evidencias.com.br","institution_ids":[]},{"raw_affiliation_string":"Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123. tobias.engel@evidencias.com.br","institution_ids":["https://openalex.org/I4210115148"]},{"raw_affiliation_string":"Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123","institution_ids":["https://openalex.org/I4210115148"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017990449","display_name":"Luciana Gontijo de Oliveira Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115148","display_name":"Kantar Health (Brazil)","ror":"https://ror.org/01j4fzm59","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210115148"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luciana Gontijo de Oliveira Clark","raw_affiliation_strings":["Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123","institution_ids":["https://openalex.org/I4210115148"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001572178","display_name":"Luciano Morganti Paladini","orcid":"https://orcid.org/0000-0002-1279-7374","observed_orcids":["https://orcid.org/0000-0002-1279-7374"]},"institutions":[{"id":"https://openalex.org/I4210115148","display_name":"Kantar Health (Brazil)","ror":"https://ror.org/01j4fzm59","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210115148"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luciano Paladini","raw_affiliation_strings":["Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123","institution_ids":["https://openalex.org/I4210115148"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089773064","display_name":"Otavio Augusto Camara Clark","orcid":"https://orcid.org/0000-0003-1607-2589","observed_orcids":["https://orcid.org/0000-0003-1607-2589"]},"institutions":[{"id":"https://openalex.org/I4210115148","display_name":"Kantar Health (Brazil)","ror":"https://ror.org/01j4fzm59","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210115148"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ot\u00e1vio Augusto C. Clark","raw_affiliation_strings":["Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidencias - A Kantar Health Company, Av. Jos\u00e9 de Souza Campos, 550 - 7\u00b0. andar (salas 71 e 72), Nova Campinas, Campinas, S\u00e3o Paulo, Brazil, 13092-123","institution_ids":["https://openalex.org/I4210115148"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210115148"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":1.2824,"has_fulltext":true,"cited_by_count":130,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83610701,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"16","issue":"1","first_page":"677","last_page":"677"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.906000018119812},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8989999890327454},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9290000200271606},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9419999718666077},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7620000243186951},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5960000157356262},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7229999899864197},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.9240000247955322},{"id":"https://openalex.org/keywords/gastrointestinal-perforation","display_name":"gastrointestinal perforation","score":0.9800000190734863},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4869999885559082},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.6460000276565552},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9334911108016968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8126097917556763},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7745445966720581},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.702338695526123},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6443701982498169},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6380306482315063},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6168332695960999},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5757147073745728},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.554598867893219},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5049551129341125},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.45658037066459656},{"id":"https://openalex.org/C2780356529","wikidata":"https://www.wikidata.org/wiki/Q279324","display_name":"Gastrointestinal perforation","level":3,"score":0.44076332449913025},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4261336028575897},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4240385890007019},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3860536813735962},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35372769832611084},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33599501848220825},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3178233504295349},{"id":"https://openalex.org/C2780199535","wikidata":"https://www.wikidata.org/wiki/Q223102","display_name":"Peritonitis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1186/s12885-016-2734-y","doi":"https://doi.org/10.1186/s12885-016-2734-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-016-2734-y","pdf_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-016-2734-y","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4997727","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4997727/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmid:27558497","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27558497","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/s12885-016-2734-y","doi":"https://doi.org/10.1186/s12885-016-2734-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-016-2734-y","pdf_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-016-2734-y","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2517864759.pdf","grobid_xml":"https://content.openalex.org/works/W2517864759.grobid-xml"},"referenced_works_count":86,"referenced_works":["https://openalex.org/W186268426","https://openalex.org/W1585383225","https://openalex.org/W1606278307","https://openalex.org/W1872421448","https://openalex.org/W1985712533","https://openalex.org/W2004515940","https://openalex.org/W2012852444","https://openalex.org/W2012932483","https://openalex.org/W2013621187","https://openalex.org/W2015414840","https://openalex.org/W2017285222","https://openalex.org/W2018991771","https://openalex.org/W2026077821","https://openalex.org/W2027176779","https://openalex.org/W2033890227","https://openalex.org/W2046000826","https://openalex.org/W2048067273","https://openalex.org/W2053083499","https://openalex.org/W2057282229","https://openalex.org/W2057806510","https://openalex.org/W2058657324","https://openalex.org/W2069030010","https://openalex.org/W2074274108","https://openalex.org/W2075642745","https://openalex.org/W2075657558","https://openalex.org/W2080109178","https://openalex.org/W2083558962","https://openalex.org/W2086082826","https://openalex.org/W2096651590","https://openalex.org/W2101322472","https://openalex.org/W2103789431","https://openalex.org/W2105683151","https://openalex.org/W2106787323","https://openalex.org/W2107328434","https://openalex.org/W2111595600","https://openalex.org/W2112727687","https://openalex.org/W2112759697","https://openalex.org/W2114148421","https://openalex.org/W2119943104","https://openalex.org/W2121368761","https://openalex.org/W2122152991","https://openalex.org/W2125435699","https://openalex.org/W2125447919","https://openalex.org/W2125857654","https://openalex.org/W2125923056","https://openalex.org/W2127941773","https://openalex.org/W2128447158","https://openalex.org/W2131881867","https://openalex.org/W2132545630","https://openalex.org/W2138075845","https://openalex.org/W2139664150","https://openalex.org/W2140614736","https://openalex.org/W2140626944","https://openalex.org/W2141276994","https://openalex.org/W2143743735","https://openalex.org/W2149084609","https://openalex.org/W2149347983","https://openalex.org/W2154399935","https://openalex.org/W2156575195","https://openalex.org/W2157010166","https://openalex.org/W2157769714","https://openalex.org/W2157823046","https://openalex.org/W2167422856","https://openalex.org/W2168579528","https://openalex.org/W2170226272","https://openalex.org/W2170552969","https://openalex.org/W2171790106","https://openalex.org/W2224689257","https://openalex.org/W2238435714","https://openalex.org/W2285531711","https://openalex.org/W2286113687","https://openalex.org/W2306149069","https://openalex.org/W2314927739","https://openalex.org/W2327814330","https://openalex.org/W2339612083","https://openalex.org/W2580868502","https://openalex.org/W2598979511","https://openalex.org/W2760434161","https://openalex.org/W2941873168","https://openalex.org/W2944229588","https://openalex.org/W3022903699","https://openalex.org/W3083236858","https://openalex.org/W4233894445","https://openalex.org/W4235545634","https://openalex.org/W4244082907","https://openalex.org/W4255483444"],"related_works":["https://openalex.org/W1983660338","https://openalex.org/W65708371","https://openalex.org/W2347592870","https://openalex.org/W2327814330","https://openalex.org/W2138075845","https://openalex.org/W2389584434","https://openalex.org/W3031352853","https://openalex.org/W3201612254","https://openalex.org/W2130867283","https://openalex.org/W2394503259"],"abstract_inverted_index":{"BACKGROUND:":[0],"Colorectal":[1],"cancer":[2,10,71],"(CRC)":[3],"is":[4],"the":[5,12,20,26,51,96,132,201,204,288,346],"fourth":[6],"most":[7],"frequently":[8],"diagnosed":[9],"and":[11,43,53,82,90,171,195,266,293,309,343,354],"second":[13],"leading":[14],"cause":[15],"of":[16,28,55,210,283,296,305,319,348],"neoplasm-related":[17],"death":[18],"in":[19,62,316,341],"United":[21],"States.":[22],"Several":[23,74],"studies":[24,97],"analyzed":[25],"efficacy":[27,359],"bevacizumab":[29,58,286,338],"combined":[30,99,133,205,362],"with":[31,64,109,154,189,285,298,334],"different":[32],"chemotherapy":[33,56,60,284,326],"regimens":[34,351],"consisting":[35],"on":[36],"drugs":[37],"such":[38],"as":[39],"5-FU,":[40],"capecitabine,":[41],"irinotecan":[42,353],"oxaliplatin.":[44],"This":[45],"systematic":[46],"review":[47],"aims":[48],"to":[49,149,166,184,219,232,246,261,275,331,363],"evaluate":[50],"effectiveness":[52],"safety":[54],"plus":[57,327,337],"versus":[59],"alone":[61],"patients":[63,297,320,332],"previously":[65],"untreated":[66],"advanced":[67],"or":[68,105,324],"metastatic":[69],"colorectal":[70],"(mCRC).":[72],"METHODS:":[73],"databases":[75],"were":[76,87,98,313],"searched,":[77],"including":[78],"MEDLINE,":[79],"EMBASE,":[80],"LILACS,":[81],"CENTRAL.":[83],"The":[84,120,281,303],"primary":[85],"endpoints":[86],"overall":[88,174,294,310],"survival":[89,158,175,292,295,307,311],"progression-free":[91,157,291,306],"survival.":[92],"Data":[93],"extracted":[94],"from":[95],"by":[100],"using":[101],"hazard":[102],"ratio":[103,107],"(HR)":[104],"risk":[106],"(RR)":[108],"their":[110],"corresponding":[111],"95":[112,145,162,180,215,228,242,257,271],"%":[113,117,146,163,181,216,229,243,258,272],"confidence":[114],"intervals":[115],"(95":[116],"CI).":[118],"RESULTS:":[119],"final":[121],"analysis":[122],"included":[123],"9":[124],"trials":[125],"comprising":[126],"3,914":[127],"patients.":[128],"Patients":[129],"who":[130],"received":[131],"treatment":[134],"(chemotherapy":[135],"+":[136],"bevacizumab)":[137],"had":[138,207],"higher":[139,156,173,208,315],"response":[140,289],"rates":[141,176,209],"(RR":[142,212,225,239,254,268],"=":[143,152,160,178,187,213,226,235,240,249,255,264,269,278],"0.89;":[144],"CI:":[147,164,182,217,230,244,259,273],"0.82":[148],"0.96;":[150],"p":[151,168,186,221,234,248,263,277],"0.003)":[153],"heterogeneity,":[155],"(HR":[159,177],"0.69;":[161],"0.63":[165],"0.75;":[167],"<":[169,222],"0.00001)":[170],"also":[172],"0.87;":[179],"0.80":[183],"0.95;":[185],"0.002)":[188],"moderate":[190],"heterogeneity.":[191],"Regarding":[192,345],"adverse":[193],"events":[194,253],"severe":[196],"toxicities":[197],"(grade":[198],"\u2265":[199],"3),":[200],"group":[202],"receiving":[203,321],"therapy":[206],"hypertension":[211],"3.56":[214],"2.58":[218],"4.92;":[220],"0.00001),":[223],"proteinuria":[224],"1.89;":[227],"1.26":[231],"2.84;":[233],"0.002),":[236],"gastrointestinal":[237],"perforation":[238],"3.63;":[241],"1.31":[245],"10.09;":[247],"0.01),":[250],"any":[251],"thromboembolic":[252],"1.44;":[256],"1.20":[260],"1.73;":[262],"0.0001),":[265],"bleeding":[267],"1.81;":[270],"1.22":[274],"2.67;":[276],"0.003).":[279],"CONCLUSION:":[280],"combination":[282],"increased":[287],"rate,":[290],"mCRC":[299],"without":[300],"prior":[301],"chemotherapy.":[302],"results":[304,360],"(PFS)":[308],"(OS)":[312],"comparatively":[314],"those":[317],"subgroups":[318],"bolus":[322],"5-FU":[323],"capecitabine-based":[325],"bevacizumab,":[328],"when":[329,361],"compared":[330],"treated":[333],"infusional":[335],"%-FU":[336],"(no":[339],"difference":[340],"PFS":[342],"OS).":[344],"type":[347],"cytotoxic":[349],"scheme,":[350],"containing":[352],"fluoropyrimidine":[355],"monotherapy":[356],"showed":[357],"superior":[358],"bevacizumab.":[364]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2517864759","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-09-16T00:00:00"}
